NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 48 min 36 sec ago

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Thu, 2024-01-18 11:46
Funding Opportunity PAR-24-122 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, healthcare delivery, and digital health and data science, and implementation science.

Notice of Change to Extend Last Receipt Date and the Expiration Date for PAR-21-185 and PAR-21-186

Thu, 2024-01-18 09:27
Notice NOT-DC-24-020 from the NIH Guide for Grants and Contracts

International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)

Thu, 2024-01-18 09:12
Funding Opportunity PAR-24-114 from the NIH Guide for Grants and Contracts. The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recently-appointed U.S. junior faculty (applicants must be at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience in a low- or middle-income country (LMIC), as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including "low-income," "lower-middle-income," and "upper-middle-income" countries) leading to an independently-funded research career focused on global health. This Funding Opportunity Announcement (FOA) invites applications from postdoctoral research scientists and junior faculty from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of the LMIC under the mentorship of LMIC and U.S. mentors.

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Wed, 2024-01-17 02:16
Funding Opportunity RFA-DA-25-060 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Notice of Extension to PAR-21-130, PAR-21-131, PAR-21-132, PAR-21-133, PAR-21-134, PAR-21-135, PAR-21-136 and PAR-21-137

Tue, 2024-01-16 11:26
Notice NOT-MH-24-155 from the NIH Guide for Grants and Contracts

NIGMS Support to Utilize Data and Biospecimens Generated by the ARDS, Pneumonia, and Sepsis Phenotyping (APS) Consortium

Tue, 2024-01-16 04:36
Notice NOT-GM-24-018 from the NIH Guide for Grants and Contracts

Notice of NIDCD Participation in PAR-23-298 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Tue, 2024-01-16 03:33
Notice NOT-DC-24-018 from the NIH Guide for Grants and Contracts

Notice of NIDCD Participation in PAR-23-299 Research to Improve Native American Health (R21 Clinical Trials Optional)

Tue, 2024-01-16 03:19
Notice NOT-DC-24-017 from the NIH Guide for Grants and Contracts

Notice of Change: Extension of PAR-21-237 "NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)" by two council rounds

Fri, 2024-01-12 01:56
Notice NOT-NS-24-033 from the NIH Guide for Grants and Contracts

Pages